• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物化学物质的生化筛选以及东莨菪亭作为严重急性呼吸综合征冠状病毒2主蛋白酶潜在抑制剂的鉴定,揭示其对结构稳定性的生物物理影响

Biochemical Screening of Phytochemicals and Identification of Scopoletin as a Potential Inhibitor of SARS-CoV-2 M, Revealing Its Biophysical Impact on Structural Stability.

作者信息

Bano Sarika, Singh Jyotishna, Zehra Zainy, Sulaimani Md Nayab, Mohammad Taj, Yumlembam Seemasundari, Hassan Md Imtaiyaz, Islam Asimul, Dey Sanjay Kumar

机构信息

Laboratory for Proteins and Structural Biology, Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India.

Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India.

出版信息

Viruses. 2025 Mar 12;17(3):402. doi: 10.3390/v17030402.

DOI:10.3390/v17030402
PMID:40143329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11945487/
Abstract

The main protease (M or 3CL or nsp5) of SARS-CoV-2 is crucial to the life cycle and pathogenesis of SARS-CoV-2, making it an attractive drug target to develop antivirals. This study employed the virtual screening of a few phytochemicals, and the resultant best compound, Scopoletin, was further investigated by a FRET-based enzymatic assay, revealing an experimental IC of 15.75 µM. The impact of Scopoletin on M was further investigated by biophysical and MD simulation studies. Fluorescence spectroscopy identified a strong binding constant of 3.17 × 10 M⁻ for Scopoletin binding to M, as demonstrated by its effective fluorescence quenching of M. Additionally, CD spectroscopy showed a significant reduction in the helical content of M upon interaction with Scopoletin. The findings of thermodynamic measurements using isothermal titration calorimetry (ITC) supported the spectroscopic data, indicating a tight binding of Scopoletin to M with a K of 2.36 × 10 M. Similarly, interaction studies have also revealed that Scopoletin forms hydrogen bonds with the amino acids nearest to the active site, and this has been further supported by molecular dynamics simulation studies. These findings indicate that Scopoletin may be developed as a potential antiviral treatment for SARS-CoV-2 by targeting M.

摘要

新型冠状病毒(SARS-CoV-2)的主要蛋白酶(M或3CL或nsp5)对SARS-CoV-2的生命周期和发病机制至关重要,使其成为开发抗病毒药物的一个有吸引力的靶点。本研究对几种植物化学物质进行了虚拟筛选,并通过基于荧光共振能量转移(FRET)的酶活性测定对筛选出的最佳化合物东莨菪亭进行了进一步研究,结果显示其实验半数抑制浓度(IC)为15.75 μM。通过生物物理和分子动力学(MD)模拟研究进一步探究了东莨菪亭对主要蛋白酶M的影响。荧光光谱法确定东莨菪亭与主要蛋白酶M结合的强结合常数为3.17×10 M⁻,M的有效荧光猝灭证明了这一点。此外,圆二色光谱(CD)显示,与东莨菪亭相互作用后,主要蛋白酶M的螺旋含量显著降低。使用等温滴定量热法(ITC)进行的热力学测量结果支持了光谱数据,表明东莨菪亭与主要蛋白酶M紧密结合,解离常数(K)为2.36×10 M。同样,相互作用研究还表明,东莨菪亭与最靠近活性位点的氨基酸形成氢键,分子动力学模拟研究进一步证明了这一点。这些研究结果表明,东莨菪亭可能通过作用于主要蛋白酶M开发成为一种潜在的抗SARS-CoV-2病毒疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/685cb36c8c5b/viruses-17-00402-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/16eb9446048c/viruses-17-00402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/6ae96288c06c/viruses-17-00402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/aff8c8865a38/viruses-17-00402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/22f8db1b25bd/viruses-17-00402-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/70151c45e34c/viruses-17-00402-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/7e1336df73f7/viruses-17-00402-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/cb912cf5c040/viruses-17-00402-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/3828abfd895b/viruses-17-00402-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/f00cc0064a7c/viruses-17-00402-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/a8467a15cd78/viruses-17-00402-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/e5593c0ac445/viruses-17-00402-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/8a2cfec6ecb2/viruses-17-00402-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/445c010ed115/viruses-17-00402-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/3da285f7eb2c/viruses-17-00402-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/9b6a68eb3a26/viruses-17-00402-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/685cb36c8c5b/viruses-17-00402-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/16eb9446048c/viruses-17-00402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/6ae96288c06c/viruses-17-00402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/aff8c8865a38/viruses-17-00402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/22f8db1b25bd/viruses-17-00402-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/70151c45e34c/viruses-17-00402-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/7e1336df73f7/viruses-17-00402-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/cb912cf5c040/viruses-17-00402-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/3828abfd895b/viruses-17-00402-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/f00cc0064a7c/viruses-17-00402-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/a8467a15cd78/viruses-17-00402-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/e5593c0ac445/viruses-17-00402-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/8a2cfec6ecb2/viruses-17-00402-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/445c010ed115/viruses-17-00402-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/3da285f7eb2c/viruses-17-00402-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/9b6a68eb3a26/viruses-17-00402-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/11945487/685cb36c8c5b/viruses-17-00402-g016.jpg

相似文献

1
Biochemical Screening of Phytochemicals and Identification of Scopoletin as a Potential Inhibitor of SARS-CoV-2 M, Revealing Its Biophysical Impact on Structural Stability.植物化学物质的生化筛选以及东莨菪亭作为严重急性呼吸综合征冠状病毒2主蛋白酶潜在抑制剂的鉴定,揭示其对结构稳定性的生物物理影响
Viruses. 2025 Mar 12;17(3):402. doi: 10.3390/v17030402.
2
Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 M protein - an in silico and cell-based approach.揭示植物化学物质抑制新型冠状病毒M蛋白的潜力——基于计算机模拟和细胞的方法
Sci Rep. 2025 Jul 2;15(1):22840. doi: 10.1038/s41598-025-05907-z.
3
Phytocompounds as versatile drug-leads targeting mProtease in the SARS-CoV-2 virus: insights from a molecular dynamics study.植物化合物作为针对 SARS-CoV-2 病毒中 m 蛋白酶的多功能药物先导物:来自分子动力学研究的见解。
J Biomater Sci Polym Ed. 2024 Nov;35(16):2528-2548. doi: 10.1080/09205063.2024.2385138. Epub 2024 Jul 30.
4
3CL of SARS-CoV-2 as a new target for bufadienolides: in silico and in vitro study.严重急性呼吸综合征冠状病毒2型的3CL作为蟾蜍二烯内酯的新靶点:计算机模拟和体外研究
J Comput Aided Mol Des. 2025 Jul 5;39(1):41. doi: 10.1007/s10822-025-00623-2.
5
Discovery of Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors through Rational Design of Novel Fluorinated 1,3,4-oxadiazole Amide Derivatives: An In-Silico Study.通过新型氟化1,3,4-恶二唑酰胺衍生物的合理设计发现严重急性呼吸综合征冠状病毒2主要蛋白酶抑制剂:一项计算机模拟研究
Chem Biodivers. 2025 Jun;22(6):e202403179. doi: 10.1002/cbdv.202403179. Epub 2025 Feb 14.
6
Structural basis for varying drug resistance of SARS-CoV-2 M E166 variants.新冠病毒M E166变体不同耐药性的结构基础
mBio. 2025 Jul 9;16(7):e0262424. doi: 10.1128/mbio.02624-24. Epub 2025 Jun 2.
7
Evaluation of inhibition effect and interaction mechanism of antiviral drugs on main protease of novel coronavirus: Molecular docking and molecular dynamics studies.评价抗病毒药物对新型冠状病毒主蛋白酶的抑制作用及相互作用机制:分子对接和分子动力学研究。
J Mol Graph Model. 2024 Dec;133:108873. doi: 10.1016/j.jmgm.2024.108873. Epub 2024 Sep 24.
8
Amphibian-Derived Peptides as Natural Inhibitors of SARS-CoV-2 Main Protease (M): A Combined In Vitro and In Silico Approach.源自两栖动物的肽作为严重急性呼吸综合征冠状病毒2主蛋白酶(M)的天然抑制剂:体外和计算机模拟相结合的方法
Chem Biodivers. 2025 Jun;22(6):e202403202. doi: 10.1002/cbdv.202403202. Epub 2025 Feb 6.
9
Virtual Screening Identifies Inhibitors of SARS-CoV-2 Main Protease through Pharmacophore and Similarity Approaches.虚拟筛选通过药效团和相似性方法鉴定出新型冠状病毒主要蛋白酶的抑制剂。
Curr Pharm Des. 2025;31(18):1461-1473. doi: 10.2174/0113816128358219241210101947.
10
Discovery of SARS-CoV-2 papain-like protease inhibitors through machine learning and molecular simulation approaches.通过机器学习和分子模拟方法发现严重急性呼吸综合征冠状病毒2木瓜样蛋白酶抑制剂
Drug Discov Ther. 2025 Jul 4;19(3):189-199. doi: 10.5582/ddt.2025.01034. Epub 2025 Jun 27.

本文引用的文献

1
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents.SARS-CoV-2 主蛋白酶(Mpro)抑制剂作为抗冠状病毒药物。
Biomolecules. 2024 Jul 4;14(7):797. doi: 10.3390/biom14070797.
2
Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication.新冠病毒治疗药物耐药性和副作用的可能机制:其根除的瓶颈。
Daru. 2024 Dec;32(2):801-823. doi: 10.1007/s40199-024-00524-z. Epub 2024 Jul 19.
3
Immunomodulating Phytochemicals: An Insight Into Their Potential Use in Cytokine Storm Situations.
免疫调节植物化学物质:对其在细胞因子风暴情况下潜在用途的洞察。
Adv Pharm Bull. 2024 Mar;14(1):105-119. doi: 10.34172/apb.2024.001. Epub 2023 Jul 19.
4
Scopoletin: a review of its pharmacology, pharmacokinetics, and toxicity.东莨菪亭:药理学、药代动力学及毒性综述
Front Pharmacol. 2024 Feb 23;15:1268464. doi: 10.3389/fphar.2024.1268464. eCollection 2024.
5
The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19.从不同临床谱 COVID-19 患者中分离的 SARS-CoV-2 的 RdRp 基因分型。
BMC Infect Dis. 2024 Mar 4;24(1):281. doi: 10.1186/s12879-024-09146-x.
6
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.COVID-19 疫苗和特殊关注的不良事件:一项涉及 9900 万接种者的多国全球疫苗数据网络(GVDN)队列研究。
Vaccine. 2024 Apr 2;42(9):2200-2211. doi: 10.1016/j.vaccine.2024.01.100. Epub 2024 Feb 12.
7
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2.黄花蒿对严重急性呼吸综合征冠状病毒2的抗病毒、杀病毒和抗氧化特性。
Biomed Pharmacother. 2023 Dec;168:115682. doi: 10.1016/j.biopha.2023.115682. Epub 2023 Oct 11.
8
Reply to Yan et al.: Quercetin possesses a fluorescence quenching effect but is a weak inhibitor against SARS-CoV-2 main protease.回复颜等人:槲皮素具有荧光猝灭作用,但对新型冠状病毒主要蛋白酶的抑制作用较弱。
Proc Natl Acad Sci U S A. 2023 Sep 12;120(37):e2309870120. doi: 10.1073/pnas.2309870120. Epub 2023 Sep 5.
9
Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease.将槲皮素重新定义为一种针对新冠病毒主要蛋白酶的广谱抑制剂。
Proc Natl Acad Sci U S A. 2023 Sep 12;120(37):e2309289120. doi: 10.1073/pnas.2309289120. Epub 2023 Sep 5.
10
The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022.2020 年至 2022 年 SARS-CoV-2 主蛋白酶抑制剂的研究进展。
Eur J Med Chem. 2023 Sep 5;257:115491. doi: 10.1016/j.ejmech.2023.115491. Epub 2023 May 22.